GROWTH OF PREMATURE INFANTS/ROSS SSC FORMULA STUDY

早产儿的生长/ROSS SSC 配方研究

• 批准号: 6295082
• 负责人: REGINALD C TSANG
• 金额: $ 3.1万
• 依托单位: CINCINNATI CHILDRENS HOSP MED CTR
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6295082
• 关键词: baby food; body weight; bone metabolism; child physical development; clinical research; developmental nutrition; dietary iron; human subject; normal ossification; nutrition related tag; premature infant human

The primary objective of this study is to determine if feeding preterm infants Reformulated Similac Special Care (RSSC) in-hospital and a specialized premature infant discharge formula (PDF) after hospital discharge will result in better bone mineralization compared to feeding Similac Special Care (SSC) in-hospital and Similac with Iron (SWI) after discharge. The secondary objective is to determine if there will be greater growth. The null hypothesis to be tested is that infants receiving RSSC in-hospital and PDF after discharge will not differ in bone mineral content (BMC) or growth from those fed SSC in-hospital and SWI after discharge, the current standard regimen.

这项研究的主要目的是确定喂养早产儿在住院后重新制定了院子里（RSSC）特殊护理（RSSC）内疗养（RSSC）和专用的早产婴儿出院配方（PDF），与喂养后孔氏菌（SSC）和用铁（SWI）相比，与进食Similac Special Care（SSC）相比，是否会导致更好的骨矿化（SSC）。 次要目标是确定是否会有更大的增长。 零假设要测试的是，出院后接受RSSC的院内和PDF的婴儿在骨矿物质含量（BMC）上不会有差异，或者与当前标准方案后的SSC SSC内部和SSC内SWI的生长不会有所不同。